Clinical Trial Update: A Phase I Study of Pazopanib in Adult Patients With Liver Cancer [Phase 1]

View source ↗

Summary

Phase I trial evaluating pazopanib in adults with hepatocellular carcinoma has been completed, focusing on safety, tolerability, and dosing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Votrient (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Carcinoma, Hepatocellular | Phase 1 | Status: COMPLETED